on 12 Sep 2023
Last Applicant/ Owned by
No.1 Yongtaizhuang North Road
Haidian Dist., Beijing
CN
100082
Serial Number
90796130 filed on 25th Jun 2021
Registration Number
7159975 registered on 12th Sep 2023
Correspondent Address
Paulo A. de Almeida
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical preparations for human biomedicine, namely, pharmaceutical preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; vaccines; drugs for medical purposes, namely, medicinal preparations used for prote Read More
Pharmaceutical preparations for human biomedicine, namely, pharmaceutical preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; vaccines; drugs for medical purposes, namely, medicinal preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; opotherapy preparations; serotherapeutic medicines, namely, medical immune serums used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; biological preparations for medical purposes, namely, biological preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; medicines for human purposes, namely, medicines used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and new coronavirus vaccine; chemical preparations for medical purposes, namely, medicinal preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and new coronavirus vaccine; adjuvants for medical purposes; Blood for medical purposes; nutraceutical preparations for therapeutic or medical purposes; immunostimulants; Medical cell function activating drugs, namely, medicinal preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; tumor suppressing agents; Anti-sarcoma preparations; cytostatics for medical purposes; Pharmaceutical products for the prevention and treatment of cancer; all the foregoing using circular ribonucleic acid (RNA)
No 90796130
No Service/Collective Mark
No
Yes
No
No
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
12th Sep 2023 | REGISTERED-PRINCIPAL REGISTER |
12th Sep 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
27th Jun 2023 | PUBLISHED FOR OPPOSITION |
27th Jun 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
07th Jun 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
19th May 2023 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
12th May 2023 | EXAMINERS AMENDMENT -WRITTEN |
12th May 2023 | EXAMINERS AMENDMENT E-MAILED |
12th May 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
12th May 2023 | EXAMINER'S AMENDMENT ENTERED |